The FINDRISC questionnaire capacity to predict diabetes mellitus II, arterial hypertension and comorbidity in women from low-and-middle-income countries

The Finnish Diabetes Risk Score (FINDRISC) has been implemented to assess diabetes risk. The authors aimed in this study to determine the prediction capacity of FINDRISC for the early detection of cardiovascular diseases in women. A prevalence study was carried out on 441 women of Pueblo Libre (Peru...

Descripción completa

Guardado en:
Autores principales: María García Rodríguez, Manuel Saldaña, José Manuel Alcaide-Leyva, Rafael Moreno Rojas, Guillermo Molina‐Recio
Formato: Artículo
Lenguaje:inglés
Publicado: 2019
Materias:
Comorbidity
Anthropometry
Diabetes mellitus
Medicine
Obesity
Blood pressure
Internal medicine
Endocrinology
Adult
Blood Glucose
Blood Pressure
Cardiovascular Diseases epidemiology
Cross-Sectional Studies
Diabetes Mellitus, Type 2 epidemiology
Female
Humans
Hypertension epidemiology
Middle Aged
Obesity epidemiology
Peru epidemiology
Predictive Value of Tests
Surveys and Questionnaires
Socioeconomic Factors
Risk Assessment methods
Health Sciences Medicine Endocrinology, Diabetes and Metabolism Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences Medicine Cardiology and Cardiovascular Medicine Blood Pressure and Hypertension Studies
Health Sciences Medicine Cardiology and Cardiovascular Medicine Cardiovascular Health and Risk Factors
Acceso en línea:Ver en el sistema de origen
Enlace permanente (DOI o Handle)
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Sumario:The Finnish Diabetes Risk Score (FINDRISC) has been implemented to assess diabetes risk. The authors aimed in this study to determine the prediction capacity of FINDRISC for the early detection of cardiovascular diseases in women. A prevalence study was carried out on 441 women of Pueblo Libre (Peru). Anthropometric variables, blood pressure, blood glucose and comorbidity were measured and entered in FINDRISC. 4.8% of the studied women suffered from DM2, 14.3% from AHT, 33% obesity and 8.6% comorbidity. We found that FINDRISC was the best method to discriminate DM, AHT and comorbidity. FINDRISC is an effective non-invasive tool for women from low-and-middle-income countries.

Ejemplares similares